Noncompetitive enzyme immunoassay for carcinoembryonic antigen by flow injection chemiluminescence

Clinica Chimica Acta

Volumn 341, Issue 1-2, 2004, Pages 109-115

  Lin, Jiehua ^a   Yan, Feng ^b   Ju, Huangxian ^a  

^a NANJING UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

Author keywords

Carcinoembryonic antigen (CEA); Chemiluminescence; Flow injection analysis; Horseradish peroxidase; Immunoaffinity; Noncompetitive enzyme immunoassay

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; HORSERADISH PEROXIDASE;

ANTIBODY AFFINITY; ANTIBODY LABELING; ARTICLE; BLOOD ANALYSIS; CHEMOLUMINESCENCE; CONJUGATE; CORRELATION COEFFICIENT; ENZYME IMMUNOASSAY; FLOW INJECTION ANALYSIS; HUMAN; IMMUNORADIOMETRIC ASSAY; INCUBATION TIME; PRIORITY JOURNAL;

ARMORACIA RUSTICANA;

EID: 1142273265     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.11.014     Document Type: Article

References (38)

1. Magdelenat H. Tumour markers in oncology: past, present and future. J. Immunol. Methods. 150:1992;133-143.
2. Schlageter M.H., Larghero J., Cassinat B., Toubert M.E., Borschneck C., Rain J.D. Serum carcinoembryonic antigen, cancer antigen 125, cancer antigen 15-3, squamous cell carcinoma, and tumor-associated trypsin inhibitor concentrations during healthy pregnancy. Clin. Chem. 44:1998;1995-1998.
3. Gold P., Freedman S.O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp. Med. 121:1965;439-462.
4. Duffy M.J., van Dalen A., Haglund C., Hansson L., Klapdor R., Lamerz R. et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur. J. Cancer. 39:2003;718-727.
5. Kleisbauer J.P., Castelnau O., Thomas P., Ramirez J., Lanteaume A., Roux F. Prognostic value of carcinoembryonic antigen in lung carcinoma before treatment. Lung Cancer. 15:1996;148.
6. Hernández L., Espasa A., Fernández C., Candela A., Martín C., Romero S. CEA and CA 549 in serum and pleural fluid of patients with pleural effusion. Lung Cancer. 36:2002;83-89.
7. Engelen M.J.A., de Bruijn H.W.A., Hollema H., ten Hoor K.A., Willemse P.H.B., Aalders J.G.et al. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Gynecol. Oncol. 78:2000;16-20.
8. Sahin B., Paydak V., Paydas S. Hepatosteatosis and alterations of CA15-3 and CEA in patients with breast cancer receiving tamoxifen. Eur. J. Cancer. 32:1996;s24.
9. Bremer K., Micus S., Bremer G. CEA, CA 15-3 and MCA: comparative clinical relevance in breast cancer. Eur. J. Cancer. 31:1995;s262.
10. Jezeršek B., Cervek J., Rudolf Z., Novakovic S. Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients. Cancer Lett. 110:1996;137-144.
11. Alumanda M.D.R., Minoru K. Trapping method of antibodies on surfaces of polymerizing discs for enzyme immunoassay. Anal. Chim. Acta. 312:1995;85-94.
12. Eckert K., Fuhrmann-Selter T., Maurer H.R., Büttner P. A colorimetric immunoassay for the detection of E-cadherin and carcinoembryonic antigen (CEA) expression on human colonic carcinoma cell lines in vitro. Cancer Lett. 105:1996;1-4.
13. Hendriks H.A., Kortlandt W., Verweij W.M. Standardized comparison of processing capacity and efficiency of five new-generation immunoassay analyzers. Clin. Chem. 46:2000;105-111.
14. Rymer J.C., Sabatier R., Daver A., Bourleaud J., Assicot M., Bremond J. et al. A new approach for clinical biological assay comparison and sstandardization: application of PCA to a Multicenter Study of Twenty-One CEA Immunoassay Kits. Clin. Chem. 45:1999;869-881.
15. Ruzicka J., Hansen E. Flow injection analysis: Part I. A new concept of fast continuous flow analysis. Anal. Chim. Acta. 78:1975;145-157.
16. Liu H.J., Yu J.C., Bindra D.S., Givens R.S., Wilson G.S. Flow injection solid-phase chemiluminescent immunoassay using a membrane-based reactor. Anal. Chem. 63:1991;666-669.
17. Luo J.X., Yang X.C. Flow injection chemiluminescent immunoassay with para-phenylphenol and sodium tetraphenylborate as synergistic enhancers. Anal. Chim. Acta. 485:2003;57-62.
18. Locascio-Brown L., Plant A.L., Horváth V., Durst R.A. Liposome flow injection immunoassay: implication for sensitivity, dynamic range and antibody regeneration. Anal. Chem. 62:1990;2587-2593.
19. Nandakumar R., Nandakumar M.P., Mattiasson B. Quantification of nisin in flow-injection immunoassay systems. Biosens. Bioelectron. 15:2000;241-247.
20. Bereczki A., Horváth V. Novel type of flow injection immunoassay for the determination of phenytoin in serum. Anal. Chim. Acta. 391:1999;9-17.
21. Bjarnason B., Bousios N., Eremin S., Johansson G. Flow injection enzyme immunoassay of atrazine herbicide in water. Anal. Chim. Acta. 347:1997;111-120.
22. Burestedt E., Kjellström S., Emnéus J., Marko-Varga G. Development of an offline noncompetitive flow immunoassay for the determination of interleukin-8 in cell samples. Anal. Biochem. 279:2000;46-54.
23. Gunaratna P.C., Wilson G.S. Noncompetitive flow injection immunoassay for a hapten, α-(difluoromethyl) ornithine. Anal. Chem. 65:1993;1152-1157.
24. Zhu Q.Z., Liu F.H., Li D.H., Xu J.G., Su W.J., Huang J.W. A novel polymer-mimetic enzyme immunoassay system based on thermal phase separating technique. Anal. Chim. Acta. 375:1998;177-185.
25. Baeyens W.R.G., Schulman S.G., Calokerinos A.C., Zhao Y., Campaña A.M.G., Nakashima K.et al. Chemiluminescence-based detection: principles and analytical applications in flowing streams and in immunoassays. J. Pharm. Biomed. Anal. 17:1998;941-953.
26. Dodeigne C., Thunus L., Lejeune R. Chemiluminescence as diagnostic tool: a review. Talanta. 51:2000;415-439.
27. Thorpe G.H.G., Kricka L.J., Gillespie E., Moseley S., Amess R., Bagget N.et al. Enhancement of the horseradish peroxidase catalyzed chemiluminescent oxidation of cyclic diacyl hydrazides by 6-hydroxy benzothiazoles. Anal. Biochem. 145:1985;96-100.
28. Zhang H.L., Horacio A.M. Carbon dioxide-enhanced luminol chemiluminescence in the absence of added oxidant. Analyst. 121:1996;211-218.
29. 2-HRP chemiluminescence: energy transfer process. J. Biolumin. Chemilumin. 12:1997;199-205.
30. Kricka L.J., Ji X.Y. Synergistic enhancement of the horseradish peroxidase-catalyzed oxidation of luminol by 4-substituted phenylboronic acids. Talanta. 44:1997;1073-1079.
31. Osipov A.P., Zaitseva N.V., Egorov A.M. Chemiluminescent immunoenzyme biosensor with a thin-layer flow-through cell. Application for study of a real-time bimolecular antigen-antibody interaction. Biosen. Bioelectron. 11:1996;881-887.
32. Díaz A.N., Sánchez F.G., Lovillo J., García J.A.G. Enhanced chemiluminescence kinetic ELISA of dichlorprop methyl ester. Anal. Chim. Acta. 321:1996;219-224.
33. Botchkareva A.E., Fini F., Eremin S., Mercader J.V., Montoya A., Girotti S. Development of a heterogeneous chemiluminescent flow immunoassay for DDT and related compounds. Anal. Chim. Acta. 453:2002;43-52.
34. Jackson T.M., Ekins R.P. Theoretical limitations on immunoassay sensitivity: current practice and potential advantages of fluorescent europium (3+) chelates as non-radioisotopic tracers. J. Immunol. methods. 87:1986;13-20.
35. Lövgren U., Kronkvist K., Bäckström B., Edholm L.E., Johansson G. Design of non-competitive flow injection enzyme immunoassays for determination of haptens: application to digoxigenin. J. Immunol. Methods. 200:1997;159-168.
36. Gascón J., Durand G., Barcelo D. Pilot survey for atrazine and total chlortrizines in estuarine waters using magnetic particle-based immunoassay and gas chromatography-nitrogen/phosphorous detection. Environ. Sci. Technol. 29:1995;1551-1556.
37. Keay R.W., McNeil C.J. Separation-free electrochemical immunosensors for rapid determination of atrazine. Biosens. Bioelectron. 13:1998;963-970.
38. Dai Z., Yan F., Chen J., Ju H.X. Reagentless amperometric immunosensors based on direct electrochemistry of horseradish peroxidase for rapid determination of carcinoma antigen-125. Anal. Chem. 75:2003;5429-5434.